[ad_1]
The National Health Surveillance Agency (Anvisa) today authorized AstraZeneca to test its possible vaccine against covid-19 in more than 5,000 volunteers in Brazil in the framework of Phase 3 clinical trials carried out in the country, reported the Federal University of São Paulo (Unifesp), which coordinates studies in the country. Brazil resumed testing.
The addition of volunteers, in addition to the 5,000 already recruited and vaccinated, will help provide stronger results on the safety and efficacy of the vaccine, Unifesp said in a note.
According to the university, volunteers over 18 years old are sought in Rio Grande do Norte and Rio Grande do Sul.
In south africa
AstraZeneca resumed testing of the company’s potential Covid-19 vaccine in South Africa, just over a week after testing was halted due to alleged serious side effects in a UK volunteer, the Department of Health said. country to Reuters today.
The move, confirmed to Reuters by South Africa’s Health Department’s director of affordable medicines, Khadija Jamaloodien, comes after the British pharmacist obtained clearance on Saturday to restart testing in the UK, prompting Brazil to perform the same.
Testing remains suspended in the United States pending an investigation into the incident, and the Serum Institute of India said it will restart its testing as soon as it gets permission from the Indian Drug Controller.
